Related Experiment Videos
Altered cell cycle kinetics, gene expression, and G1 restriction point regulation in Rb-deficient fibroblasts
R E Herrera1, V P Sah, B O Williams
1Whitehead Institute for Biomedical Research, Cambridge, Massachusetts 02142, USA.
Abstract:
Fibroblasts prepared from retinoblastoma (Rb) gene-negative mouse embryos exhibit a shorter G1 phase of the growth cycle and smaller size than wild-type cells. In addition, the mutant cells are no longer inhibited by low levels of cycloheximide at any point in G1 but do remain sensitive to serum withdrawal until late in G1. Certain cell cycle-regulated genes showed no temporal or quantitative differences in expression. In contrast, cyclin E expression in Rb-deficient cells is deregulated in two ways. Cyclin E mRNA is generally derepressed in mutant cells and reaches peak levels about 6 h earlier in G1 than in wild-type cells. Moreover, cyclin E protein levels are higher in the Rb-/- cells than would be predicted from the levels of its mRNA. Thus, the selective growth advantage conferred by Rb gene deletion during tumorigenesis may be explained in part by changes in the regulation of cyclin E. In addition, the mechanisms defining the restriction point of late G1 may consist of at least two molecular events, one cycloheximide sensitive and pRb dependent and the other serum sensitive and pRb independent.
Insights
Retinoblastoma (Rb) gene deletion in mouse fibroblasts alters cell cycle regulation, specifically affecting cyclin E expression and G1 phase progression. This deregulation may contribute to tumor development by conferring a selective growth advantage.
Area of Science:
- Molecular Biology
- Cell Biology
- Genetics
Background:
- The retinoblastoma (Rb) protein is a crucial tumor suppressor regulating the cell cycle.
- Understanding Rb's role in cell cycle control is vital for cancer research.
Purpose of the Study:
- To investigate the impact of retinoblastoma (Rb) gene deletion on fibroblast cell cycle progression.
- To elucidate the specific changes in gene expression and protein regulation in Rb-deficient cells.
Main Methods:
- Culturing and analyzing fibroblasts from Rb gene-negative mouse embryos.
- Assessing cell size, cell cycle phase duration (G1), and response to chemical inhibitors (cycloheximide, serum withdrawal).
- Quantifying and analyzing the expression of cell cycle-regulated genes, including cyclin E mRNA and protein levels.
Main Results:
- Rb-deficient fibroblasts exhibit a shortened G1 phase and smaller cell size compared to wild-type.
- Mutant cells show altered sensitivity to cycloheximide and serum withdrawal during G1.
- Cyclin E expression is deregulated in Rb-deficient cells, with earlier and higher mRNA and protein levels.
Conclusions:
- Rb gene deletion confers a selective growth advantage, partly due to altered cyclin E regulation.
- The restriction point in late G1 involves at least two molecular events: one pRb-dependent and cycloheximide-sensitive, the other pRb-independent and serum-sensitive.